Publication:
The release of the bromodomain ligand N,N-dimethylacetamide adds bioactivity to a resorbable guided bone regeneration membrane in a rabbit calvarial defect model

dc.contributor.authorBarbara Siegenthaleren_US
dc.contributor.authorChafik Ghayoren_US
dc.contributor.authorNisarat Ruangsawasdien_US
dc.contributor.authorFranz E. Weberen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Zurichen_US
dc.date.accessioned2020-03-26T04:49:39Z
dc.date.available2020-03-26T04:49:39Z
dc.date.issued2020-02-01en_US
dc.description.abstract© 2020 by the authors. N,N-Dimethylacetamide (DMA) is FDA approved as an excipient and is used as drug-delivery vehicle. Due to its amphipathic nature and diverse bioactivities, it appears to be a good combination of biodegradable poly-lactide-co-glycolide (PLGA)-based guided bone regeneration membranes. Here we show that the solvent DMA can be loaded to PLGA membranes by different regimes, leading to distinct release profiles, and enhancing the bone regeneration in vivo. Our results highlight the potential therapeutic benefits of DMA in guided bone regeneration procedures, in combination with biodegradable PLGA membranes.en_US
dc.identifier.citationMaterials. Vol.13, No.3 (2020)en_US
dc.identifier.doi10.3390/ma13030501en_US
dc.identifier.issn19961944en_US
dc.identifier.other2-s2.0-85079290883en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/53711
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079290883&origin=inwarden_US
dc.subjectMaterials Scienceen_US
dc.titleThe release of the bromodomain ligand N,N-dimethylacetamide adds bioactivity to a resorbable guided bone regeneration membrane in a rabbit calvarial defect modelen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079290883&origin=inwarden_US

Files

Collections